/ /

  • linkedin
  • Increase Font
  • Sharebar

    Extended-depth-of-focus IOLs expand surgical options

    Point/counterpoint among surgeons examines IOL benefits, compares with existing lenses




    1. Lum F, Tarver ME, Kahook MY, et al. Special Commentary: Food and Drug Administration and American Academy of Ophthalmology Sponsored: Developing Novel End Points for Premium Intraocular Lenses Workshop. Ophthalmology. 2015;122:1522-1531.



    Daniel H. Chang, MD

    E: [email protected]

    This article was adapted from a debate at the 2015 meeting of the American Academy of Ophthalmology, in which Dr. Chang and Dr. Dell presented these perspectives on this topic. Dr. Chang indicated a financial relationship with Abbott Medical Optics, Allergan, Carl Zeiss Meditec, ClarVista Medical, Mynosys Cellular Devices, Omega Ophthalmics, and Rapid Pathogen Screening.


    Steven J. Dell, MD

    E: [email protected]

    Dr. Dell indicated a financial relationship with Abbott Medical Optics, Advanced Tear Diagnostics, Allergan, Bausch + Lomb, Ocular Therapeutix, Optical Express, Presbyopia Therapies, and Tracey Technologies.

    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results